Raymon Heather has filed 13 insider transactions across 1 company since September 2024.
Most recent transaction: a grant/award of 46000 shares of Artiva Biotherapeutics, Inc. ($ARTV) on February 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | A | Common Stock | 46000 | $0.00 | 152,844.0000 | 24,544,904 | 43.05% | 0.19% |
| Feb. 15, 2026 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | F | Common Stock | 1521 | $4.00 | 151,323.0000 | 24,544,904 | 1.00% | 0.01% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | D | Employee Stock Option (Right to Buy) | 18239 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.07% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | A | Common Stock | 67253 | $0.00 | 106,844.0000 | 24,544,904 | 169.87% | 0.27% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | D | Employee Stock Option (Right to Buy) | 12539 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.05% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | D | Employee Stock Option (Right to Buy) | 14819 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.06% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | D | Employee Stock Option (Right to Buy) | 11399 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.05% |
| Dec. 12, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | D | Employee Stock Option (Right to Buy) | 10259 | $0.00 | 0.0000 | 24,544,904 | 100.00% | 0.04% |
| Nov. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | F | Common Stock | 1375 | $3.25 | 39,591.0000 | 24,544,904 | 3.36% | 0.01% |
| Aug. 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | F | Common Stock | 1639 | $2.75 | 40,966.0000 | 24,363,119 | 3.85% | 0.01% |
| May 15, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | F | Common Stock | 745 | $2.13 | 42,605.0000 | 24,363,119 | 1.72% | 0.00% |
| Feb. 26, 2025 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | A | Common Stock | 33350 | $0.00 | 43,350.0000 | 0 | 333.50% | 0.00% |
| Sept. 12, 2024 | Artiva Biotherapeutics, Inc. | $ARTV | Raymon Heather | SVP, Research and Development | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |